Professor Matt Ringel, Endocrine-Related Cancer’s Editor-in-Chief, and the Editorial Board, have highlighted articles from each issue of the journal that are unique, high quality and stand out amongst current hormone-related cancer research.
Explore the collection of articles below to further your understanding of the latest advances in endocrine-related cancer. All articles have been made freely available for all to read.
Most recent Editor's choice articles
COVID-19 and androgen-targeted therapy for prostate cancer patients
Neil A Bhowmick et al.
Mendelian randomization supports a causative effect of TSH on thyroid carcinoma
Jonathan M Fussey et al.
GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours
Johan O Paulsson et al.
Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth
Manisha Taya et al.
Soluble CD105 is prognostic of disease recurrence in prostate cancer patients
Veronica R Placencio-Hickok et al.
Oncometabolite induced primary cilia loss in pheochromocytoma
Samuel M O’Toole et al.
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
Martin K Bakht et al.
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Esben Andreas Carlsen et al.
Non-canonical AR activity facilitates endocrine resistance in breast cancer
KeeMing Chia et al.
Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model
Fabia De Oliveira Andrade et al.
UCHL1 loss alters the cell cycle in metastatic pancreatic neuroendocrine tumors
Brendan M Finnerty et al.
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny
Fiorenza Gianì et al.
MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition
Christina M Knippler et al.
The molecular genetic make-up of male breast cancer
Cathy B Moelans et al.